Company Overview of Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. operates as a biopharmaceutical company that develops microRNA-based oncology therapeutics. It offers MRX34 to deliver a mimic of the naturally occurring microRNA tumor suppressor, miR-34, which is lost or under expressed in tumors of patients with various cancers, including cervical cancer, ovarian cancer, glioblastoma, hepatocellular carcinoma (liver cancer), colon cancer, non-small cell lung cancer, and in cancer stem cells. The company was founded in 2007 and is based in Austin, Texas. Mirna Therapeutics, Inc. operates as a subsidiary of Asuragen, Inc.
2150 Woodward Street
Austin, TX 78744
Founded in 2007
Key Executives for Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Principio, Inc.||United States|
|VLST Corporation||United States|
|allvivo, Inc.||United States|
|PharmaGenoma, Inc.||United States|
|Amplimmune, Inc.||United States|
Recent Private Companies Transactions
March 31, 2015
To contact Mirna Therapeutics, Inc., please visit www.mirnatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.